Literature DB >> 24393152

The use of dermal substitutes in burn surgery: acute phase.

Shahriar Shahrokhi1, Anna Arno, Marc G Jeschke.   

Abstract

Major burns represent a challenge in autologous skin coverage and may lead to severe functional and cosmetic sequelae. Dermal substitutes are increasingly becoming an essential part of burn care during the acute phase of treatment. In the long term dermal substitutes improve functional and cosmetic results and thus enhance quality of life. In the chronic wound setting, dermal substitutes are used to reconstruct and improve burn scars and defects. Despite the potential of dermal substitutes, further research is required to strengthen scientific evidence regarding their effects and also to develop new technologies and products. Furthermore, dermal substitutes have a pivotal role in future research strategies as they have the potential to provide adequate scaffold for stem cells, tissue engineering, and regenerative medicine with conceivable application of obtaining long-lasting and scarless artificial skin. This review discusses the status quo of dermal substitutes and novel strategies in the use of dermal substitutes with a focus on burn care.
© 2014 by the Wound Healing Society.

Entities:  

Mesh:

Year:  2014        PMID: 24393152      PMCID: PMC3884830          DOI: 10.1111/wrr.12119

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  55 in total

1.  Longitudinal assessment of Integra in primary burn management: a randomized pediatric clinical trial.

Authors:  Ludwik K Branski; David N Herndon; Clifford Pereira; Ronald P Mlcak; Mario M Celis; Jong O Lee; Arthur P Sanford; William B Norbury; Xiao-Jun Zhang; Marc G Jeschke
Journal:  Crit Care Med       Date:  2007-11       Impact factor: 7.598

2.  Management of full-thickness skin defects in the hand and wrist region: first long-term experiences with the dermal matrix Matriderm.

Authors:  W Haslik; L-P Kamolz; F Manna; M Hladik; T Rath; M Frey
Journal:  J Plast Reconstr Aesthet Surg       Date:  2008-11-30       Impact factor: 2.740

3.  Cultured skin substitutes: a review.

Authors:  S T Boyce
Journal:  Tissue Eng       Date:  1996

4.  Integra artificial skin in use for full-thickness burn surgery: benefits or harms on patient outcome.

Authors:  Andreas Fette
Journal:  Technol Health Care       Date:  2005       Impact factor: 1.285

Review 5.  Tissue-engineered skin. Current status in wound healing.

Authors:  Y M Bello; A F Falabella; W H Eaglstein
Journal:  Am J Clin Dermatol       Date:  2001       Impact factor: 7.403

6.  Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system.

Authors:  S T Andreadis; K E Hamoen; M L Yarmush; J R Morgan
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

7.  Reconstruction of the radial forearm free flap donor site using integra artificial dermis.

Authors:  Ryan C Murray; Eli A Gordin; Kapil Saigal; Douglas Leventhal; Howard Krein; Ryan N Heffelfinger
Journal:  Microsurgery       Date:  2010-10-11       Impact factor: 2.425

8.  Complex wound management utilizing an artificial dermal matrix.

Authors:  Pornprom Muangman; Loren H Engrav; David M Heimbach; Nobuyuki Harunari; Shari Honari; Nicole S Gibran; Matthew B Klein
Journal:  Ann Plast Surg       Date:  2006-08       Impact factor: 1.539

9.  Design of an artificial skin. II. Control of chemical composition.

Authors:  I V Yannas; J F Burke; P L Gordon; C Huang; R H Rubenstein
Journal:  J Biomed Mater Res       Date:  1980-03

10.  Comparison of dermal substitutes in wound healing utilizing a nude mouse model.

Authors:  Anh-Tuan N Truong; Areta Kowal-Vern; Barbara A Latenser; Dorion E Wiley; Robert J Walter
Journal:  J Burns Wounds       Date:  2005-03-14
View more
  38 in total

Review 1.  Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions.

Authors:  Saeid Amini-Nik; Yusef Yousuf; Marc G Jeschke
Journal:  Adv Drug Deliv Rev       Date:  2017-07-27       Impact factor: 15.470

2.  German, European or American burn guidelines - Is one superior to another?

Authors:  F J Paprottka; N Krezdorn; K Young; R Ipaktchi; D Hebebrand; P M Vogt
Journal:  Ann Burns Fire Disasters       Date:  2016-03-31

Review 3.  Methodologies in creating skin substitutes.

Authors:  Mathew N Nicholas; Marc G Jeschke; Saeid Amini-Nik
Journal:  Cell Mol Life Sci       Date:  2016-05-06       Impact factor: 9.261

4.  Comparative experimental study of wound healing in mice: Pelnac versus Integra.

Authors:  Ana Carolina Câmara Wosgrau; Talita da Silva Jeremias; Dilmar Francisco Leonardi; Maurício José Pereima; Gabriella Di Giunta; Andrea Gonçalves Trentin
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

5.  Examining the contribution of surrounding intact skin during cutaneous healing.

Authors:  Makram E Aljghami; Marc G Jeschke; Saeid Amini-Nik
Journal:  J Anat       Date:  2019-02-20       Impact factor: 2.610

6.  Engineered alternative skin for partial and full-thickness burns.

Authors:  Quenton Wessels
Journal:  Bioengineered       Date:  2014-03-20       Impact factor: 3.269

Review 7.  Stem Cells and Tissue Engineering: Regeneration of the Skin and Its Contents.

Authors:  Amy L Strong; Michael W Neumeister; Benjamin Levi
Journal:  Clin Plast Surg       Date:  2017-04-22       Impact factor: 2.017

8.  Treatment of third-degree burn wounds in animal specimens: acellular dermis or partial-thickness skin graft.

Authors:  M J Fatemi; M Momeni; A Tavakoli; T Bagheri; A Hosseini; S Araghi; F Ranjpoor; A Zavareh
Journal:  Ann Burns Fire Disasters       Date:  2018-06-30

9.  Cellularized Bilayer Pullulan-Gelatin Hydrogel for Skin Regeneration.

Authors:  Mathew N Nicholas; Marc G Jeschke; Saeid Amini-Nik
Journal:  Tissue Eng Part A       Date:  2016-05       Impact factor: 3.845

10.  Skin Substitutes for Adults With Diabetic Foot Ulcers and Venous Leg Ulcers: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2021-06-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.